https://doi.org/10.18093/0869-0189-2014-0-2-84-90
About the Authors
A. G. VolkovaRussian Federation
M. G. Sharapov
Russian Federation
V. K. Ravin
Russian Federation
A. E. Gordeeva
Russian Federation
E. V. Karaduleva
Russian Federation
E. K. Mubarakshina
Russian Federation
A. A. Temnov
Russian Federation
E. E. Fesenko
Russian Federation
V. I. Novoselov
Russian Federation
References
1. Day B.J. Antioxidant therapeutics: Pandora's box. Free Radic. Biol. Med. 2014; 66: 58–64.
2. Xiang J., Jiang Y. Regulation of Cu-Zn superoxide dismutase on SCN2A in SH-SY5Y cells as a potential therapy for temporal lobe epilepsy. Mol. Med. Respir. 2014; 9: 16–22.
3. Yang C., Chen H.X., Zhou Y. et al. Manganese superoxide dismutase gene therapy protects against irradiationinduced intestinal injury. Curr. Gene Ther. 2013; 13: 305–314.
4. Carillon J., Rouanet J.M., Cristol J.P., Brion R. Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: several routes of supplementation and proposal of an original mechanism of action. Pharm. Res. 2013; 30: 2718–2728.
5. Shi X., Shi Z., Huang H. et al. PEGylated human catalase elicits potent therapeutic effects on H1N1 influenzainduced pneumonia in mice. Appl. Microbiol. Biotechnol. 2013; 97: 10025–10033.
6. Shi H., Yu H.J., Wang H.Y. et al. Topical administration of peroxiredoxin-6 on the cornea suppresses inflammation and neovascularization induced by ultraviolet radiation. Invest. Ophthalmol. Vis. Sci. 2012, 53, 8016–8028.
7. Novoselov S.V., Peshenko I.V., Popov V.V. et al. Localization of the 28-kDa peroxiredoxin in rat epithelial tissues and its antioxidant properties. Cell. Tissue Respir. 2001; 298: 471–480.
8. Новоселов В.И., Амелина С.Е., Кравченко И.Н. и др. Роль пероксиредоксина в антиоксидантной системе органов дыхания. Доклады РАН. 2000; 375 (6): 831–833. / Novoselov V.I., Amelina S.E., Kravchenko I.N. et al. A role of peroxiredoxin in the antioxidant system of the respiratory tract. Report of the Russian Academy of Sciences. 2000; 375 (6): 831–833 (in Russian).
9. Chuchalin A.G., Novoselov V.I., Shifrina O.N. et al. Peroxiredoxin VI in human respiratory system. Respir. Med. 2003; 97; 147–151.
10. Новоселов В.И. Роль пероксиредоксинов при окислительном стрессе в органах дыхания. Пульмонология. 2012; 10: 80–88. / Novoselov V.I. A role of peroxiredoxins during antioxidative stress in the respiratory tract. Pul'monologiya. 2012; 10: 80–88 (in Russian).
11. Новоселов В.И., Барышникова Л.М., Янин В.А. и др. Влияние пероксиредоксина VI на заживление резаной раны. Доклады РАН. 2003, 378, 412–414. / Novoselov V.I., Baryshnikova L.M., Yanin V.A. et al. An influence of peroxiredoxin VI on slash wound repair. Report of the Russian Academy of Science 2003, 378, 412–414 (in Russian).
12. Новоселов В.И., Равин В.К., Шарапов М.Г. и др. Модифицированные пероксиредоксины как прототипы лекарственных препаратов мощного антиоксидантного действия. Биофизика 2011; 56: 873–880. / Novoselov V.I., Ravin V.K., Sharapov M.G. et al. Modifyed peroxiredoxins as potent antioxidant drug precursors. Biofizika 2011; 56: 873–880 (in Russian).
Review
For citations:
Volkova A.G., Sharapov M.G., Ravin V.K., Gordeeva A.E., Karaduleva E.V., Mubarakshina E.K., Temnov A.A., Fesenko E.E., Novoselov V.I. . PULMONOLOGIYA. 2014;(2):84-90. (In Russ.) https://doi.org/10.18093/0869-0189-2014-0-2-84-90